TABLE 4: Distribution of time from triage to clinical outcomes according to study arm.

	Arm 1			Arm 2
Time (days) from triage to	MGIT	Xpert	P-value	MGIT	LPA	P-value
	N (IQR)	N (IQR)		N (IQR)	N (IQR)
Sputum collection	0 (0-0)	0 (0-0.75)	0.71	0 (0-0)	0 (0-1.00)	0.87
DST results release	32.5 (27.2-47.0)	2.2 (0-2.5)	<0.001	34.0 (22-62.0)	9.0 (7-15.0)	<0.001
DST results received by the physician	55.5 (38.2-103.5)	7.0 (3-13.3)	<0.001	40.2 (27.2-65.7)	30.0 (9-33.2)	<0.001
Changing treatment	47 (35-87.7)	30.0 (6.7-42.7)	0.005	69.0 (46-84.0)	61.0 (34-121.0)	0.99
Treatment that matches with standard reference DST	40.5 (28.7-76.7)	15.0 (4.5-38.5)	0.01	54.0 (17-80.5)	61.4 (19.7-104.7)	0.78

Legend: IQR: interquartile range; DST: drug susceptibility testing; MGIT: BactecTMMGITTM 960 system; Xpert: Xpert® MTB/RIF; LPA: line probe assay.